Population
Cardiomyocytes (preclinical model)
Design
Preclinical
Authors
Loading...
Epac pathway merits testing in hypertrophy models; leaves open any role in human cardiac remodeling or therapy.
Epac is identified as a novel positive regulator of cardiac growth, mediating cAMP-induced cardiomyocyte hypertrophy via Rac and calcineurin/NFAT signaling.
Morel et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: